Clinical trial
The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study
NCT04077580 is registered in ClinicalTrials.gov with University of Oslo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study
- Lead sponsor
- University of Oslo
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 1, 2019
- Completion date
- June 30, 2023
- Enrollment
- 289 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent urinary tract infection